NovelStem International Corp. (NSTM)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 3.53 Million USD | 53.14% |
| 2022 | 434.43 Thousand USD | -12.33% |
| 2021 | 495.53 Thousand USD | -11.82% |
| 2020 | 561.95 Thousand USD | 0.0% |
| 2013 | 3.18 Million USD | -49.57% |
| 2012 | 6.31 Million USD | -35.67% |
| 2011 | 9.82 Million USD | -15.75% |
| 2010 | 11.65 Million USD | -54.39% |
| 2009 | 25.56 Million USD | -21.99% |
| 2008 | 32.76 Million USD | -19.15% |
| 2007 | 40.52 Million USD | 0.63% |
| 2006 | 40.27 Million USD | 8.89% |
| 2005 | 36.98 Million USD | 42.18% |
| 2004 | 26.01 Million USD | 17.08% |
| 2003 | 22.21 Million USD | -77.12% |
| 2002 | 97.09 Million USD | 60.25% |
| 2001 | 60.58 Million USD | -11.14% |
| 2000 | 68.18 Million USD | 148.84% |
| 1999 | 27.4 Million USD | 86.39% |
| 1998 | 14.7 Million USD | 20.49% |
| 1997 | 12.2 Million USD | 23.23% |
| 1996 | 9.9 Million USD | 5.32% |
| 1995 | 9.4 Million USD | 42.42% |
| 1994 | 6.6 Million USD | 633.33% |
| 1993 | 900 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 144.03 Thousand USD | -21.43% |
| 2024 Q1 | 183.3 Thousand USD | 512.72% |
| 2023 Q1 | 164.79 Thousand USD | -2.89% |
| 2023 FY | 665.27 Thousand USD | 53.14% |
| 2023 Q2 | 2.71 Million USD | 1549.97% |
| 2023 Q4 | 29.91 Thousand USD | -64.47% |
| 2023 Q3 | 84.2 Thousand USD | -96.9% |
| 2022 Q3 | 206.21 Thousand USD | -10.18% |
| 2022 FY | 434.43 Thousand USD | -12.33% |
| 2022 Q1 | -171.04 Thousand USD | -231.98% |
| 2022 Q2 | 229.57 Thousand USD | 234.22% |
| 2022 Q4 | 169.69 Thousand USD | -17.71% |
| 2021 Q4 | 129.59 Thousand USD | -2.69% |
| 2021 Q3 | 133.17 Thousand USD | -29.76% |
| 2021 Q2 | 189.6 Thousand USD | 61.11% |
| 2021 FY | 495.53 Thousand USD | -11.82% |
| 2021 Q1 | 117.68 Thousand USD | 0.0% |
| 2020 FY | 561.95 Thousand USD | 0.0% |
| 2013 Q2 | 1.29 Million USD | -10.44% |
| 2013 Q3 | 1.4 Million USD | 8.37% |
| 2013 Q4 | 607.28 Thousand USD | -56.87% |
| 2013 Q1 | 1.45 Million USD | -38.38% |
| 2013 FY | 3.18 Million USD | -49.57% |
| 2012 FY | 6.31 Million USD | -35.67% |
| 2012 Q3 | 1.15 Million USD | -33.77% |
| 2012 Q1 | 1.68 Million USD | -1.79% |
| 2012 Q4 | 2.35 Million USD | 103.96% |
| 2012 Q2 | 1.74 Million USD | 3.43% |
| 2011 FY | 9.82 Million USD | -15.75% |
| 2011 Q3 | 2.64 Million USD | 7.86% |
| 2011 Q2 | 2.44 Million USD | -18.93% |
| 2011 Q1 | 3.01 Million USD | 136.9% |
| 2011 Q4 | 1.71 Million USD | -34.99% |
| 2010 Q2 | 6.68 Million USD | 5.88% |
| 2010 Q3 | 6.83 Million USD | 2.3% |
| 2010 Q4 | -8.18 Million USD | -219.62% |
| 2010 FY | 11.65 Million USD | -54.39% |
| 2010 Q1 | 6.31 Million USD | -15.34% |
| 2009 Q3 | 5.91 Million USD | 0.7% |
| 2009 Q2 | 5.87 Million USD | -7.01% |
| 2009 FY | 25.56 Million USD | -21.99% |
| 2009 Q1 | 6.31 Million USD | -23.74% |
| 2009 Q4 | 7.45 Million USD | 26.12% |
| 2008 FY | 32.76 Million USD | -19.15% |
| 2008 Q4 | 8.28 Million USD | 5.25% |
| 2008 Q3 | 7.86 Million USD | -24.26% |
| 2008 Q2 | 10.38 Million USD | -3.68% |
| 2008 Q1 | 10.78 Million USD | 1.54% |
| 2007 Q2 | 10.9 Million USD | -1.12% |
| 2007 Q1 | 11.02 Million USD | 0.92% |
| 2007 Q4 | 10.62 Million USD | 4.42% |
| 2007 FY | 40.52 Million USD | 0.63% |
| 2007 Q3 | 10.17 Million USD | -6.71% |
| 2006 Q3 | 9.78 Million USD | -10.07% |
| 2006 FY | 40.27 Million USD | 8.89% |
| 2006 Q4 | 10.92 Million USD | 11.61% |
| 2006 Q2 | 10.88 Million USD | 19.89% |
| 2006 Q1 | 9.07 Million USD | -5.35% |
| 2005 Q3 | 8.9 Million USD | -6.83% |
| 2005 FY | 36.98 Million USD | 42.18% |
| 2005 Q4 | 9.59 Million USD | 7.78% |
| 2005 Q2 | 9.55 Million USD | 6.92% |
| 2005 Q1 | 8.93 Million USD | 82.12% |
| 2004 Q1 | 6.69 Million USD | 95.75% |
| 2004 Q2 | 6.5 Million USD | -2.86% |
| 2004 Q4 | 4.9 Million USD | -37.92% |
| 2004 Q3 | 7.9 Million USD | 21.5% |
| 2004 FY | 26.01 Million USD | 17.08% |
| 2003 Q2 | 6.15 Million USD | -1.88% |
| 2003 Q3 | 6.35 Million USD | 3.22% |
| 2003 Q4 | 3.42 Million USD | -46.2% |
| 2003 FY | 22.21 Million USD | -77.12% |
| 2003 Q1 | 6.27 Million USD | -21.26% |
| 2002 Q1 | 11.88 Million USD | -45.48% |
| 2002 Q2 | 11.56 Million USD | -2.72% |
| 2002 Q4 | 7.97 Million USD | -87.87% |
| 2002 Q3 | 65.72 Million USD | 468.33% |
| 2002 FY | 97.09 Million USD | 60.25% |
| 2001 Q4 | 21.8 Million USD | 69.0% |
| 2001 FY | 60.58 Million USD | -11.14% |
| 2001 Q2 | 13.07 Million USD | 2.15% |
| 2001 Q1 | 12.8 Million USD | -43.48% |
| 2001 Q3 | 12.9 Million USD | -1.34% |
| 2000 Q4 | 22.65 Million USD | 38.18% |
| 2000 Q2 | 15.88 Million USD | 18.47% |
| 2000 FY | 68.18 Million USD | 148.84% |
| 2000 Q1 | 13.4 Million USD | -2.12% |
| 2000 Q3 | 16.39 Million USD | 3.19% |
| 1999 Q1 | 2.7 Million USD | -47.06% |
| 1999 Q4 | 13.7 Million USD | 95.71% |
| 1999 Q3 | 7 Million USD | 62.79% |
| 1999 Q2 | 4.3 Million USD | 59.26% |
| 1999 FY | 27.4 Million USD | 86.39% |
| 1998 FY | 14.7 Million USD | 20.49% |
| 1998 Q3 | 2.8 Million USD | -17.65% |
| 1998 Q2 | 3.4 Million USD | 3.03% |
| 1998 Q1 | 3.3 Million USD | -23.26% |
| 1998 Q4 | 5.1 Million USD | 82.14% |
| 1997 Q4 | 4.3 Million USD | 43.33% |
| 1997 Q3 | 3 Million USD | 11.11% |
| 1997 Q2 | 2.7 Million USD | 12.5% |
| 1997 Q1 | 2.4 Million USD | -27.27% |
| 1997 FY | 12.2 Million USD | 23.23% |
| 1996 Q1 | 2.3 Million USD | -28.13% |
| 1996 Q2 | 1.9 Million USD | -17.39% |
| 1996 FY | 9.9 Million USD | 5.32% |
| 1996 Q4 | 3.3 Million USD | 32.0% |
| 1996 Q3 | 2.5 Million USD | 31.58% |
| 1995 FY | 9.4 Million USD | 42.42% |
| 1995 Q1 | -5.6 Million USD | -269.7% |
| 1995 Q4 | 3.2 Million USD | 77.78% |
| 1995 Q3 | 1.8 Million USD | 133.33% |
| 1995 Q2 | -5.4 Million USD | 3.57% |
| 1994 Q2 | 1 Million USD | 211.11% |
| 1994 Q3 | 1.8 Million USD | 80.0% |
| 1994 Q4 | 3.3 Million USD | 83.33% |
| 1994 FY | 6.6 Million USD | 633.33% |
| 1994 Q1 | -900 Thousand USD | -50.0% |
| 1993 Q4 | -600 Thousand USD | 0.0% |
| 1993 Q3 | - USD | 100.0% |
| 1993 Q2 | -500 Thousand USD | 0.0% |
| 1993 Q1 | -500 Thousand USD | 0.0% |
| 1993 FY | 900 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Bio Medica Corporation | 1.04 Million USD | -237.254% |
| Arrayit Corporation | 6.19 Million USD | 42.916% |
| Atlantic International Corp. | 5.57 Million USD | 36.579% |
| Biocept, Inc. | 29.4 Million USD | 87.967% |
| Bioqual, Inc. | 7.44 Million USD | 52.505% |
| CardioGenics Holdings Inc | 772.14 Thousand USD | -358.18% |
| DermTech, Inc. | 104.01 Million USD | 96.599% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | 97.875% |
| HTG Molecular Diagnostics, Inc. | 22.62 Million USD | 84.362% |
| iMD Companies, Inc. | 151.8 Thousand USD | -2230.428% |
| IDenta Corp. | 662.97 Thousand USD | -433.625% |
| Interpace Biosciences, Inc. | 20.23 Million USD | 82.514% |
| Integrative Health Technologies, Inc. | 38.88 Thousand USD | -8999.043% |
| InVitro International | 661.32 Thousand USD | -434.957% |
| Lumos Diagnostics Holdings Limited | 7.09 Million USD | 50.158% |
| Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | -5987.898% |
| Medical Imaging Corp. | 1.91 Million USD | -85.015% |
| Optigenex Inc. | 1.28 Million USD | -174.702% |
| PharmChem, Inc. | 2.93 Million USD | -20.693% |
| Proteome Sciences plc | 3.26 Million USD | -8.256% |
| Response Genetics, Inc | 25.31 Million USD | 86.027% |
| Rennova Health, Inc. | 7.67 Million USD | 53.922% |
| RushNet, Inc. | 1.78 Million USD | -97.718% |
| ScreenPro Security Inc. | 3.23 Million USD | -9.228% |
| Stella Diagnostics Inc. | 11.42 Million USD | 69.04% |
| StageZero Life Sciences Ltd. | 7.34 Million USD | 51.821% |
| Todos Medical Ltd. | 14.05 Million USD | 74.834% |